Artiva Biotherapeutics ARTV
NASDAQ ARTV
$6.83 +0.04 (+0.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Artiva Biotherapeutics (ARTV) Price to Sales (2024)

Updated

Artiva Biotherapeutics' Price to Sales was 452.15 in Q4 2024, up 302.8% from the prior quarter.

Analysis

Artiva Biotherapeutics (ARTV) Price to Sales (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Artiva Biotherapeutics 269.19 Mn 269.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 452.15
Sep 30, 2024 112.25
API Access

Artiva Biotherapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=ARTV&period=max&api_key=YOUR_API_KEY